EUVIMEDEUVIMED entdecken
Crossref

Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities

Silje Michelsen Solberg

European Journal of Dermatology · 2023

DOI: 10.1684/ejd.2023.4585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Silje Michelsen Solberg. Beteiligte Einrichtung: Department of Dermatology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Psoriasis, Arthritis, Psoriatic, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2PsoriasisArthritis, PsoriaticHypertensionHumansComorbidityPrescriptionsRegistries

Stichwörter der Autor:innen

anxietycardiovascular diseasecomorbiditiesdepressioninflammatory bowel diseasepsoriasis

Autor:innen und Institutionen

  • Department of Dermatology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Zitieren

APA

Solberg, S. M. (2023). Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4585

Vancouver

Solberg SM. Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4585

BibTeX
@article{Solberg2023,
  author = {Solberg, Silje Michelsen},
  title = {Psoriasis in Norway: a prescription-based registry study of psoriasis-associated comorbidities},
  journal = {European Journal of Dermatology},
  year = {2023},
  doi = {10.1684/ejd.2023.4585}
}
Kostenlos starten →